Article PDF
Avoid common mistakes on your manuscript.
References
K. Repke, Proc. First Intern. Pharm. Meeting, Stockholm (1961), (Pergamon Press, Oxford 1963), vol. III, p. 47.
H. J. Portius, I. Herrmann undK. Repke, Arch. exp. Path. Pharmak.241, 534 (1961).
K. Pepke, Arch. exp. Path. Pharmak.241, 165 (1960).
D. E. Green, Advanc. Enzymol.1, 177 (1941).
W. Wilbrandt, Wien. med. Wschr.108, 809 (1958).
J. B. Kahn Jr., Proc. First Intern. Pharm. Meeting, Stockholm (1961), (Pergamon Press, Oxford 1963), vol. III, p. 111.
A. Farah undP. N. Witt, Proc. First Intern. Pharm. Meeting, Stockholm (1961), (Pergamon Press, Oxford 1963), vol. III, p. 137.
K. S. Lee, Proc. First Intern. Pharm. Meeting, Stockholm (1961), (Pergamon Press, Oxford 1963), vol. III, p. 185.
P. G. Waser, Schweiz. med. Wschr.92, 819 (1962).
M. Weatherall, inCiba Foundation Symposium on Enzymes and Drug Action (1962), (Eds.J. L. Mongar undA. V. S. de Reuck, J. & A. Churchill Ltd., London 1962), p. 115.
J. C. Skou, inSymposium on Membrane Transport and Metabolism (Ed.A. Kleinzeller undA. Kotyk, Publishing House of the Czechoslovak Academy of Sciences, Prague 1961), p. 228.
W. F. White undW. T. Salter, Fed. Proc.5, 200 (1946).
A. M. Wedd undH. A. Blair, Proc. Soc. exp. Biol. Med. N.Y.68, 304 (1948).
A. Wollenberger undM. L. Karsh, J. Pharm. exp. Therap.105, 477 (1952).
S. Ellis, J. Pharm. exp. Therap.109, 233 (1953).
A. Loubatières undA. Sassine, J. Physiol. (Paris)46, 444 (1954).
E. Rothlin, M. Taeschler undA. Cerletti, Circul. Res.3, 32 (1955).
C. C. Gruhzit undA. E. Farah, J. Pharm. exp. Therap.114, 334 (1955).
R. F. Furchgott undK. S. Lee, Circulation24, 416 (1961).
K. Lohmann undP. Ohlmeyer, inPhysiologische Chemie (Hrsg.B. Flaschenträger undE. Lehnartz, Springer Verlag, Berlin-Göttingen-Heidelberg 1956), Bd. II/2a, p. 570.
A. Wollenberger, Acta biol. med. germ. Suppl.-Bd. I, 135 (1961).
A. Fleckenstein, E. Gerlach, J. Janke undP. Marmier, Pflügers Arch. ges. Physiol.271, 75 (1960).
A. A. Infante undR. E. Davies, Biochem. biophys. Res. Comm.9, 410 (1962).
R. D. Keynes, inSymposium on Membrane Transport and Metabolism (Ed.A. Kleinzeller undA. Kotyk, Publishing House of the Czechoslovak Academy of Sciences, Prague 1961), p. 131.
H. J. Portius undK. Repke, Arch. exp. Path. Pharmak.243, 335 (1962).
H. J. Portius undK. Repke, Mber. Dt. Akad. Wiss.5, 88 (1963).
K. Repke undH. J. Portius, Mber. Dt. Akad. Wiss.5, 90 (1963).
H. J. Portius undK. Repke, Mber. Dt. Akad. Wiss.5, 193 (1963).
T. H. Schiebler, Münch. med. Wschr.103, 1 (1961).
H. Stutz, E. Feigelson, J. Emerson undR. J. Bing, Circul. Res.2, 555 (1954).
A. A. Sekul undW. C. Holland, Amer. J. Physiol.199, 457 (1960).
K. Kojima undK. Matsusaki, Acta med. Univ. Kagoshima3, 14 (1960).
PauI. S. Edelman, Ann. Rev. Physiol.23, 37 (1961).
R. D. Keynes undG. W. Maisel, Proc. Roy. Soc. B.142, 383 (1954).
R. Whittam, Nature (London)191, 603 (1961).
K. Pfleger, W. Rummel, E. Seifen undJ. Baldauf, Med. exp.5, 473 (1961).
J. Wolff, Biochim. biophys. Acta38, 316 (1960).
W. F. Widdas, Biochem. Pharm.8, 123 (1961).
J. Wolff undN. S. Halmi, J. biol. Chem.238, 847 (1963).
Ch. Tamm, Proc. First Intern. Pharm. Meeting, Stockholm (1961) (Pergamon Press 1963), vol. III.
I. M. Glynn, J. Physiol. (London)136, 148 (1957).
E. T. Dunham undI. M. Glynn, J. Physiol. (London)156, 274 (1961).
K. Repke undH. J. Portius, Arch. exp. Path. Pharmak.241, 535 (1961).
C. Lindig undK. Repke, Mber. Dt. Akad. Wiss.5, 237 (1963).
K. Repke, II Conferentia hungarica pro Therapia et Investigatione in Pharmacologia (Budapest 1962) (Akadémiai Kiadó, Budapest), im Druck.
H. M. Maling undO. Krayer, J. Pharm. exp. Therap.86, 66 (1946).
J. B. Kahn Jr., Fed. Proc.21, 149 (1962).
G. Dalma, Helv. chim. Acta22, 1497 (1939).
S. Garb undM. B. Chenoweth, Amer. J. Physiol.156, 27 (1949).
L. Tardos, Acta physiol. hung.7, 319 (1955).
B. Katzung undA. Farah, Amer. J. Physiol.184, 557 (1956).
H. F. Meyer undW. R. Kukovetz, Arch. exp. Path. Pharmak.242, 409 (1962).
R. S. Tuttle, P. N. Witt undA. Farah, J. Pharm. exp. Therap.137, 24 (1962).
H. B. Steinbach, inSymposia of the Society for Experimental Biology, Nr. VIII (Cambridge University Press, London 1954), p. 438.
F. G. Gollan, G. Rudolph undN. S. Oslen, Amer. J. Physiol.189, 227 (1957).
C. Edwards undE. J. Harris, J. Physiol. (London)135, 567 (1957).
R. D. Keynes undR. C. Swan, J. Physiol. (London)147, 591 (1959).
H. Fischer, Arch. exp. Path. Pharmak.135, 39 (1928).
M. Taeschler undH. Weidmann, Helv. physiol. Acta15, C 81 (1957).
P. R. Saunders undP. N. Sanyal, J. Pharm. exp. Therap.123, 161 (1958).
H. F. Häusler undM. Wieland, Arch. exp. Path. Pharmak.242, 403 (1962).
A. J. Clark, Proc. Roy. Soc. Med.5, 181 (1912).
O. Loewi, Arch. exp. Path. Pharmak.82, 131 (1918).
R. Caviezel undW. Wilbrandt, Helv. physiol. Acta16, 12 (1958).
K. S. Lee, D. H. Yu, D. I. Lee undR. Burstein, J. Pharm. exp. Therap.132, 139 (1961).
W. C. Holland undA. Sekul, J. Pharm. exp. Therap.133, 288 (1961).
A. K. Solomon, T. J. Gill undG. L. Gold, J. gen. Physiol.40, 327 (1956).
S. S. Schreiber, M. Oratz undM. A. Rothschild, Amer. J. Physiol.200, 1055 (1961).
P. C. Caldwell undR. D. Keynes, J. Physiol. (London)148, 8 P (1959).
R. L. Post undC. D. Albright, inSymposium on Membrane Transport and Metabolism (Ed.A. Kleinzeller undA. Kotyk, Publishing House of the Czechoslovak Academy of Sciences, Prague 1961), p. 219.
J. F. Hoffmann, Fed. Proc.21, 145 (1962).
R. Hazard, J. Hazard undJ. Thouvenot, Arch. int. Pharmacodyn.105, 33 (1956).
J. B. Kahn Jr., J. Pharm. exp. Therap.136, 197 (1962).
B. F. Hoffman, E. Binder undE. F. Suckling, Amer. J. Physiol.185, 95 (1956).
R. Niedergerke, J. Physiol. (London)134, 569 (1956).
J. Lee undJ. W. Woodbury, Fed. Proc.17, 94 (1958).
R. Caviezel, H. Koller undW. Wilbrandt, Helv. physiol. Acta16, 22 (1958).
R. D. Keynes, Proc. Roy. Soc. B142, 359 (1954).
H. Hoditz, Arch. exp. Path. Pharmak.243, 338 (1962).
J. B. Kahn Jr., J. Pharm. exp. Therap.123, 263 (1958).
E. Seifen, W. Rummel undJ. Baldauf, Arch. exp. Path. Pharmak.243, 349 (1962).
H. Fischer, Arch. exp. Path. Pharmak.130, 194 (1928).
W. Nyiri undL. DuBois, J. Pharm. exp. Therap.39, 111 (1930).
W. T. Salter, L. J. Sciarini undJ. Gemmel, J. Pharm. exp. Therap.96, 372 (1949).
M. Reiter, Pflügers Arch. ges. Physiol.267, 158 (1958).
B. Rayner undM. Weatherall, Brit. J. Pharm.12, 371 (1957).
J. D. Judah, K. Ahmed undA. E. M. McLean, Nature (London)196, 484 (1962).
W. C. Holland, R. L. Klein undA. H. Briggs, Amer. J. Physiol.196, 478 (1959).
R. L. Klein undW. C. Holland, Amer. J. Physiol.196, 1292 (1959).
S. E. Simon, M. Muller undD. G. Satchell, Biochim. biophys. Acta60, 126 (1962).
G. Grupp, Fed. Proc.21, 132 (1962).
J. F. Hoffman, Circulation26, 1201 (1962).
W. Wilbrandt, Schweiz. med. Wschr.85, 315 (1955).
P. N. Sanyal undP. R. Saunders, J. Pharm. exp. Therap.122, 499 (1958).
M. Vassalle, J. Karis undB. F. Hoffman, Amer. J. Physiol.203, 433 (1962).
J. W. Woodbury, Fed. Proc.22, 31 (1963).
L. B. Nanninga, Biochim. biophys. Acta54, 338 (1961).
S. Weidmann, Amer. Heart J.61, 298 (1961).
L. J. Mullins undA. S. Frumento, Fed. Proc.20, 142 (1961).
R. Niedergerke undE. J. Harris, Nature (London)179, 1068 (1957).
I. De B. Daly undA. J. Clark, J. Physiol. (London)54, 367 (1921).
W. Wilbrandt undH. Koller, Helv. physiol. Acta6, 208 (1948).
H. C. Lüttgau undR. Niedergerke, J. Physiol. (London)143, 486 (1958).
S. Winegrad, Circulation24, 523 (1961).
P. Whittam undJ. S. Willis, J. Physiol. (London)163, 45 P (1962).
Errechnet für eine intravenöse Dosis von 1,2 mg Digitoxin bzw. 1,6 mg Lanatosid C, von der etwa 1% bzw. 5% (vgl.2,111) auf das Herz (200 g) entfallen.
H. J. Bretschneider, P. Doering, W. Eger, G. Haberland, K. Kochsiek, H. Mercker, F. Scheler undG. Schulze, Arch. exp. Path. Pharmak.244, 117 (1962).
R. L. Vick undJ. B. Kahn Jr., J. Pharm. exp. Therap.121, 389 (1957).
T. Brown, G. Grupp undG. H. Acheson, J. Pharm. exp. Therap.129, 42 (1960).
T. E. Brown, G. H. Acheson undG. Grupp, J. Pharm. exp. Therap.136, 107 (1962).
F. E. Hunter Jr. undO. H. Lowry, Pharm. Rev.8, 89 (1956).
R. Ammon, Pflügers Arch. ges. Physiol.214, 678 (1926).
A. A. Sekul undW. C. Holland, Amer. J. Physiol.197, 752 (1959).
H. L. Conn Jr. undJ. C. Wood, Amer. J. Physiol.197, 631 (1959).
W. v. Weizsäcker, Arch. exp. Path. Pharmak.72, 282 (1913).
B. v. Issekutz, Arch. exp. Path. Pharmak.78, 155 (1915).
P. N. Saunders undP. R. Sanyal, J. Pharm. exp. Therap.122, 499 (1958).
R. S. Tuttle undA. Farah, J. Pharm. exp. Therap.135, 142 (1962).
E. F. Gersmeyer undW. C. Holland, Klin. Wschr.41, 103 (1963).
W. Klaus, G. Kuschinsky undH. Lüllmann, Arch. exp. Path. Pharmak.242, 480 (1962).
R. S. Tuttle, P. N. Witt undA. Farah, J. Pharm. exp. Therap.133, 281 (1961).
H. J. Schatzmann undP. N. Witt, J. Pharm. exp. Therap.112, 501 (1954).
P. N. Witt, J. Pharm. exp. Therap.119, 195 (1957).
W. C. Holland undR. L. Klein, Fed. Proc.18, 403 (1959).
J. Dudel undW. Trautwein, Arch. exp. Path. Pharmak.232, 393 (1958).
K. S. Lee, J. Pharm. exp. Therap.132, 149 (1961).
H. J. Portius undK. Repke, Acta biol. med. germ., im Druck.
K. S. Lee, A. Schwartz undR. Burstein, J. Pharm. exp. Therap.129, 123 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Repke, K., Portius, H.J. Über die Identität der Ionenpumpen-ATPase in der Zellmembran des Herzmuskels mit einem Digitalis-Rezeptorenzym. Experientia 19, 452–458 (1963). https://doi.org/10.1007/BF02150643
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02150643